Scancell Provides Update from iSCIB1+ Clinical Advisory Meeting to Strengthen Plans for Phase 2/3 Registration Clinical Trial To download click here
Scancell extends Convertible Loan Note redemption dates by a further two years To download click here
Change of Nominated Advisor Scancell Holdings announces appointment of Panmure Gordon as the Company’s Nominated Advisor To download click here